Skip to content

    Heartburn/GERD Health Center

    Font Size
    A
    A
    A

    FDA OKs New GERD Drug Kapidex

    Once-Daily Formula Approved to Treat GERD and Erosive Esophagitis
    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    Feb. 6, 2009 -- The FDA has approved Kapidex delayed-release capsules as a once-daily treatment for gastroesophageal reflux disease (GERD) and for erosive esophagitis, which is GERD-related damage to the esophagus.

    Kapidex, which is taken orally, belongs to a class of drugs called proton pump inhibitors. It's the first proton pump inhibitor with a dual delayed release formulation, which provides two separate releases of medication, according to Takeda Pharmaceutical Company, which makes Kapidex.

    In a news release, Takeda says that the FDA approved Kapidex based on global studies of about 6,000 GERD patients, some of whom had erosive esophagitis. In those studies, Kapidex trumped a placebo at treating heartburn. Among erosive esophagitis patients studied, those taking Kapidex also showed high healing rates of erosive esophagitis that were comparable to erosive esophagitis healing rates among patients taking Prevacid, another proton pump inhibitor made by Takeda.

    Takeda reports that the most commonly reported adverse reactions with Kapidex included diarrhea, abdominal pain, nausea, upper respiratory tract infection, vomiting, and flatulence.

    Today on WebMD

    Woman eating pizza
    How it starts, and how to stop it.
    man with indigestion
    Get lifestyle and diet tips.
     
    woman shopping for heartburn relief
    Medication options.
    man with heartburn
    Symptoms of both.
     
    digestive health
    Slideshow
    Heartburn or Heart Attack
    Article
     
    heartburn
    Article
    stomach acid rising
    Article
     
    Woman eating pizza
    Slideshow
    digestive myths
    Slideshow
     
    Extreme Eats
    Slideshow
    Bowl of pasta and peppers
    Slideshow